Drugs / MT1980
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05429840 | Jun → Oct 2022 | neuronitis | Monument Therapeutics Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MT1980 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05429840 ↗ |
| Route | Oral | “single oral dose of MT1980” NCT05429840 ↗ |